Oklahoma, www.OK.gov <{$map[0].NAME}>

Contact  |  A-Z Health Index  |  Events & Meetings

get adobe reader

What to Report

Oklahoma Administrative Code (OAC) 310:515 specifies which diseases and conditions are reportable and the timeframe and methods for reporting.

Reportable Disease Rules – OAC 310:515

The Disease Reporting Manual further defines the specifics for clinical and laboratory reporting requirements for diseases and conditions. In addition to reporting requirements, the manual contains guidance in determining if an event should be reported, and specifies which specimens and isolates are required to be forwarded to the OSDH Public Health Laboratory. 

Oklahoma Disease Reporting Manual

Reportable diseases and conditions poster(s):

Reportable Diseases/Conditions Poster for Healthcare Providers

Reportable Pathogens Poster for Laboratories

The following diseases are to be reported to the OSDH by PHIDDO or telephone (405-271-4060) immediately upon suspicion, diagnosis, or positive test:
 

Anthrax Measles (Rubeola) Poliomyelitis
Bioterrorism-suspected disease Meningococcal invasive
disease
Rabies
Botulism Novel coronavirus Smallpox
Diphtheria Novel influenza A Typhoid fever
Free-living amebae infections causing primary amebic meningoencephalitis Outbreaks of apparent infectious disease Viral hemorrhagic fever
Hepatitis B during
pregnancy (HBsAg+)
Plague  

The following diseases are to be reported to the OSDH by PHIDDO or telephone within one business day:
 

Acid Fast Bacillus (AFB) positive smear (only if no additional testing is performed or subsequent testing is indicative of Mycobacterium tuberculosis Complex) Lyme disease
AIDS (Acquired Immunodeficiency Syndrome) Malaria
Anaplasmosis Mumps
Brucellosis Pertussis
California serogroup virus infection Powassan virus infection
Campylobacteriosis Psittacosis
Chikungunya virus infection Q Fever
Congenital rubella syndrome Rubella
Cryptosporidiosis Salmonellosis
Dengue fever Shigellosis
Eastern equine encephalitis virus infection Spotted Fever Rickettsiosis (Rickettsia spp.) hospitalization or death
E. coli O157, O157:H7 or a Shiga toxin producing E. coli (STEC) St. Louis encephalitis virus infection
Ehrlichiosis Streptococcal disease, invasive, Group A (GAS)
Haemophilus influenza invasive disease Streptococcus pneumoniae invasive disease,
children <5 yrs.
Hantavirus infection, without pulmonary syndrome Syphilis (Nontreponemal and treponemal tests are reportable. If any syphilis test is       positive, then all syphilis test results on the panel must be reported. For infants
Hantavirus pulmonary syndrome Tetanus
Hemolytic uremic syndrome, postdiarrheal Trichinellosis
Hepatitis A (Anti-HAV-IgM+) Tuberculosis
Hepatitis B (HBsAg+, anti-HBc IgM+, HBeAg+, and/or HBV DNA+) 1 Tularemia
Hepatitis C virus (having jaundice or ALT ≥ 200  with laboratory confirmation) 1 Unusual disease or syndrome
Human Immunodeficiency Virus (HIV) infection Vibriosis including cholera
Influenza associated hospitalization or death West Nile virus infection
Legionellosis Western Equine encephalitis virus infection
Leptospirosis Yellow fever
Listeriosis Zika virus infection 

 1 with entire Hepatitis panel results      

The following diseases are to be reported to the OSDH by PHIDDO or telephone within one month:
 

CD4 Cell Count with cell count %
(by laboratories only)
Creutzfeldt-Jakob disease HIV viral load
(by laboratories only)
Chlamydial infections
(C. trachomatis)
Gonorrhea  


Isolates of the following organisms must be sent to the OSDH Public Health Laboratory: P.O. Box 24106 OKC, OK 73124:
 

Bacillus anthracis Mycobacterium tuberculosis
Brucella spp. N. meningitidis (sterile site isolates only)
Carbapenem-resistant Enterobacteriaceae Plasmodium spp.
E. coli O157, O157:H7 or a Shiga toxin producing E. coli Salmonella spp.
Francisella tularensis

Vibrionaceae family (Vibrio spp., Grimontia spp.,     Photobacterium spp., and other genera in the family) 

H. influenzae (sterile site isolates only)   Yersinia spp.
Listeria spp. (sterile site isolates only)  


Occupational or Environmental diseases:

The following laboratory results for adults and children must be reported to the OSDH Oklahoma Childhood Lead Poisoning Prevention Program.  

Laboratories and health care providers doing in-office testing must report blood lead level results equal to or greater than 5 µg/dL within one (1) week and results less than 5 µg/dL within one (1) month.

Laboratories and all health care providers must report blood lead level results of 20 µg/dL or greater within twenty-four (24) hours.

Creating a State of Health Logo PHB seal Oklahoma Works Logo Oklahoma Supports Logo